AFTER many years in the making, the Access to Medical Cannabis Act finally made it through the House of Representatives. The law passed on third and final reading with 177 House members voting in favor, 9 against and 9 abstaining. A counterpart bill authored by Sen. Robinhood Padilla is being deliberated in the Senate.
Medical cannabis, in the context of the House bill, "refers to concentrates, topicals, tinctures, edibles, cannabis products such as capsules and oil, including hemp, flower and any other product in their appropriate finished form, and any other derivative in their pharmaceutical formulation which shall have detailed and accurate information regarding the concentration of tetrahydrocannabinol (THC) and cannabidiol (CBD) certified by the [Medical Cannabis Office] to qualified patients for medical purpose." THC and CBD are two of about 540 chemical substances that the cannabis plant contains.
Continue reading with one of these options:
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)